Do analysts rate STVN or ZBH?

Zimmer Biomet has a consensus target price of $102.00, suggesting a potential upside of 8.28%. Given Zimmer Biomet's higher possible upside, analysts plainly believe Zimmer Biomet is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00 Zimmer Biomet 4 Sell rating(s) 12 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.24

Does the media prefer STVN or ZBH?

In the previous week, Zimmer Biomet had 15 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for Zimmer Biomet and 2 mentions for Stevanato Group. Zimmer Biomet's average media sentiment score of 0.90 beat Stevanato Group's score of 0.54 indicating that Zimmer Biomet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zimmer Biomet 8 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate SOLV or STVN?

Solventum currently has a consensus target price of $86.00, suggesting a potential upside of 0.36%. Given Solventum's higher possible upside, analysts plainly believe Solventum is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.46 Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00

Which has better earnings & valuation, SOLV or STVN?

Solventum has higher revenue and earnings than Stevanato Group. Solventum is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solventum $8.26B 1.80 $1.56B $8.16 10.50 Stevanato Group €1.34B 4.49 €158.21M €0.59 33.71

Does the media refer more to SOLV or STVN?

In the previous week, Solventum had 9 more articles in the media than Stevanato Group. MarketBeat recorded 11 mentions for Solventum and 2 mentions for Stevanato Group. Solventum's average media sentiment score of 0.78 beat Stevanato Group's score of 0.54 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate STVN or SNN?

Smith & Nephew SNATS has a consensus price target of $30.93, indicating a potential downside of 1.92%. Given Smith & Nephew SNATS's higher probable upside, analysts plainly believe Smith & Nephew SNATS is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00 Smith & Nephew SNATS 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17

Which has better earnings and valuation, STVN or SNN?

Smith & Nephew SNATS has higher revenue and earnings than Stevanato Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stevanato Group €1.34B 4.49 €158.21M €0.59 33.71 Smith & Nephew SNATS $6.16B 2.16 $625M N/A N/A

Does the media prefer STVN or SNN?

In the previous week, Smith & Nephew SNATS had 3 more articles in the media than Stevanato Group. MarketBeat recorded 5 mentions for Smith & Nephew SNATS and 2 mentions for Stevanato Group. Smith & Nephew SNATS's average media sentiment score of 0.68 beat Stevanato Group's score of 0.54 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew SNATS 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate STVN or PEN?

Penumbra has a consensus target price of $367.07, indicating a potential upside of 14.21%. Given Penumbra's higher possible upside, analysts plainly believe Penumbra is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00 Penumbra 1 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.12

Which has higher earnings & valuation, STVN or PEN?

Penumbra has higher revenue and earnings than Stevanato Group. Stevanato Group is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stevanato Group €1.34B 4.49 €158.21M €0.59 33.71 Penumbra $1.40B 9.02 $177.69M $4.07 78.97

Does the media prefer STVN or PEN?

In the previous week, Penumbra had 15 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for Penumbra and 2 mentions for Stevanato Group. Penumbra's average media sentiment score of 0.92 beat Stevanato Group's score of 0.54 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 11 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer STVN or GKOS?

Glaukos has a consensus target price of $177.33, indicating a potential upside of 6.49%. Given Glaukos' higher probable upside, analysts clearly believe Glaukos is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00 Glaukos 1 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.73

Which has higher earnings and valuation, STVN or GKOS?

Stevanato Group has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stevanato Group €1.34B 4.49 €158.21M €0.59 33.71 Glaukos $507.44M 19.35 -$187.69M -$3.25 N/A

Is STVN or GKOS more profitable?

Stevanato Group has a net margin of 11.76% compared to Glaukos' net margin of -30.68%. Stevanato Group's return on equity of 10.27% beat Glaukos' return on equity. Company Net Margins Return on Equity Return on Assets Stevanato Group 11.76% 10.27% 6.08% Glaukos -30.68% -6.37% -4.78%

Does the media refer more to STVN or GKOS?

In the previous week, Glaukos had 30 more articles in the media than Stevanato Group. MarketBeat recorded 32 mentions for Glaukos and 2 mentions for Stevanato Group. Glaukos' average media sentiment score of 0.72 beat Stevanato Group's score of 0.54 indicating that Glaukos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Glaukos 11 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Stevanato Group (STVN) Competitors

€19.89 +0.04 (+0.21%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

€19.85 -0.04 (-0.21%)

As of 07/31/2026 04:10 PM Eastern

Compare

STVN vs. ZBH, SOLV, SNN, PEN, and GKOS

Should you buy Stevanato Group stock or one of its competitors? MarketBeat compares Stevanato Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Stevanato Group include Zimmer Biomet (ZBH), Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), and Glaukos (GKOS).

How does Stevanato Group compare to Zimmer Biomet?

Stevanato Group (NYSE:STVN) and Zimmer Biomet (NYSE:ZBH) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Stevanato Group has a net margin of 11.76% compared to Zimmer Biomet's net margin of 9.05%. Zimmer Biomet's return on equity of 13.24% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
Zimmer Biomet	9.05%	13.24%	7.28%

Stevanato Group has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Zimmer Biomet has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market.

Zimmer Biomet has a consensus target price of $102.00, suggesting a potential upside of 8.28%. Given Zimmer Biomet's higher possible upside, analysts plainly believe Zimmer Biomet is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
Zimmer Biomet	4 Sell rating(s)	12 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.24

Zimmer Biomet has higher revenue and earnings than Stevanato Group. Zimmer Biomet is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.49	€158.21M	€0.59	33.71
Zimmer Biomet	$8.23B	2.21	$705.20M	$3.85	24.47

In the previous week, Zimmer Biomet had 15 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for Zimmer Biomet and 2 mentions for Stevanato Group. Zimmer Biomet's average media sentiment score of 0.90 beat Stevanato Group's score of 0.54 indicating that Zimmer Biomet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zimmer Biomet	8 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

88.9% of Zimmer Biomet shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Zimmer Biomet beats Stevanato Group on 11 of the 17 factors compared between the two stocks.

How does Stevanato Group compare to Solventum?

Solventum (NYSE:SOLV) and Stevanato Group (NYSE:STVN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

Solventum currently has a consensus target price of $86.00, suggesting a potential upside of 0.36%. Given Solventum's higher possible upside, analysts plainly believe Solventum is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.46
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

Solventum has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market.

In the previous week, Solventum had 9 more articles in the media than Stevanato Group. MarketBeat recorded 11 mentions for Solventum and 2 mentions for Stevanato Group. Solventum's average media sentiment score of 0.78 beat Stevanato Group's score of 0.54 indicating that Solventum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Solventum has a net margin of 17.33% compared to Stevanato Group's net margin of 11.76%. Solventum's return on equity of 23.51% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.33%	23.51%	7.63%
Stevanato Group	11.76%	10.27%	6.08%

Solventum has higher revenue and earnings than Stevanato Group. Solventum is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.26B	1.80	$1.56B	$8.16	10.50
Stevanato Group	€1.34B	4.49	€158.21M	€0.59	33.71

Summary

Solventum beats Stevanato Group on 10 of the 15 factors compared between the two stocks.

How does Stevanato Group compare to Smith & Nephew SNATS?

Stevanato Group (NYSE:STVN) and Smith & Nephew SNATS (NYSE:SNN) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

Smith & Nephew SNATS has higher revenue and earnings than Stevanato Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.49	€158.21M	€0.59	33.71
Smith & Nephew SNATS	$6.16B	2.16	$625M	N/A	N/A

Stevanato Group has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

25.6% of Smith & Nephew SNATS shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Smith & Nephew SNATS had 3 more articles in the media than Stevanato Group. MarketBeat recorded 5 mentions for Smith & Nephew SNATS and 2 mentions for Stevanato Group. Smith & Nephew SNATS's average media sentiment score of 0.68 beat Stevanato Group's score of 0.54 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew SNATS	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Stevanato Group has a net margin of 11.76% compared to Smith & Nephew SNATS's net margin of 0.00%. Stevanato Group's return on equity of 10.27% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
Smith & Nephew SNATS	N/A	N/A	N/A

Smith & Nephew SNATS has a consensus price target of $30.93, indicating a potential downside of 1.92%. Given Smith & Nephew SNATS's higher probable upside, analysts plainly believe Smith & Nephew SNATS is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Stevanato Group beats Smith & Nephew SNATS on 8 of the 15 factors compared between the two stocks.

How does Stevanato Group compare to Penumbra?

Stevanato Group (NYSE:STVN) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

Stevanato Group has a net margin of 11.76% compared to Penumbra's net margin of 10.67%. Penumbra's return on equity of 10.50% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
Penumbra	10.67%	10.50%	8.17%

Stevanato Group has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

88.9% of Penumbra shares are held by institutional investors. 2.9% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Penumbra has higher revenue and earnings than Stevanato Group. Stevanato Group is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.49	€158.21M	€0.59	33.71
Penumbra	$1.40B	9.02	$177.69M	$4.07	78.97

In the previous week, Penumbra had 15 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for Penumbra and 2 mentions for Stevanato Group. Penumbra's average media sentiment score of 0.92 beat Stevanato Group's score of 0.54 indicating that Penumbra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	11 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Penumbra has a consensus target price of $367.07, indicating a potential upside of 14.21%. Given Penumbra's higher possible upside, analysts plainly believe Penumbra is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
Penumbra	1 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.12

Summary

Penumbra beats Stevanato Group on 13 of the 17 factors compared between the two stocks.

How does Stevanato Group compare to Glaukos?

Stevanato Group (NYSE:STVN) and Glaukos (NYSE:GKOS) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

Stevanato Group has a net margin of 11.76% compared to Glaukos' net margin of -30.68%. Stevanato Group's return on equity of 10.27% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
Glaukos	-30.68%	-6.37%	-4.78%

99.0% of Glaukos shares are owned by institutional investors. 5.9% of Glaukos shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Glaukos has a consensus target price of $177.33, indicating a potential upside of 6.49%. Given Glaukos' higher probable upside, analysts clearly believe Glaukos is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
Glaukos	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, Glaukos had 30 more articles in the media than Stevanato Group. MarketBeat recorded 32 mentions for Glaukos and 2 mentions for Stevanato Group. Glaukos' average media sentiment score of 0.72 beat Stevanato Group's score of 0.54 indicating that Glaukos is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Glaukos	11 Very Positive mention(s)	4 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Stevanato Group has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.49	€158.21M	€0.59	33.71
Glaukos	$507.44M	19.35	-$187.69M	-$3.25	N/A

Stevanato Group has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Glaukos has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

Summary

Stevanato Group beats Glaukos on 9 of the 17 factors compared between the two stocks.

Get Stevanato Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STVN vs. The Competition

Export

Metric	Stevanato Group	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	€6.02B	€9.08B	€6.86B	€23.66B
Dividend Yield	N/A	1.47%	2.59%	4.21%
P/E Ratio	33.71	59.27	282.30	31.00
Price / Sales	4.49	101.59	561.34	81.85
Price / Cash	22.50	25.63	28.60	18.73
Price / Book	3.58	5.05	10.98	4.76
Net Income	€158.21M	€57.47B	€3.49B	€1.07B
7 Day Performance	0.52%	-0.24%	-0.60%	-0.34%
1 Month Performance	4.78%	-4.52%	-5.20%	-0.53%
1 Year Performance	-20.88%	14.90%	62.01%	19.19%

Stevanato Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STVN Stevanato Group	2.9407 of 5 stars	€19.89 +0.2%	N/A	-20.9%	€6.02B	€1.34B	33.71	6,010	Positive News Upcoming Earnings
ZBH Zimmer Biomet	3.1926 of 5 stars	$95.57 +3.8%	$102.00 +6.7%	+3.9%	$18.49B	$8.23B	24.82	17,000	Positive News Upcoming Earnings
SOLV Solventum	2.9574 of 5 stars	$86.26 +7.2%	$86.00 -0.3%	+19.5%	$14.94B	$8.26B	10.57	20,000	Positive News Upcoming Earnings
SNN Smith & Nephew SNATS	1.9857 of 5 stars	$32.54 +4.5%	$30.93 -4.9%	+2.1%	$13.75B	$6.16B	N/A	16,988	News Coverage Upcoming Earnings Gap Down High Trading Volume
PEN Penumbra	2.9928 of 5 stars	$320.00 +0.2%	$360.33 +12.6%	+32.5%	$12.59B	$1.40B	73.73	4,700	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:STVN) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stevanato Group (STVN) Competitors

STVN vs. ZBH, SOLV, SNN, PEN, and GKOS

How does Stevanato Group compare to Zimmer Biomet?

Summary

How does Stevanato Group compare to Solventum?

Summary

How does Stevanato Group compare to Smith & Nephew SNATS?

Summary

How does Stevanato Group compare to Penumbra?

Summary

How does Stevanato Group compare to Glaukos?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STVN vs. The Competition

Stevanato Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stevanato Group (STVN) Competitors

STVN vs. ZBH, SOLV, SNN, PEN, and GKOS

How does Stevanato Group compare to Zimmer Biomet?

Is STVN or ZBH more profitable?

Which has more risk & volatility, STVN or ZBH?

Do analysts rate STVN or ZBH?

Which has higher earnings & valuation, STVN or ZBH?

Does the media prefer STVN or ZBH?

Do institutionals & insiders hold more shares of STVN or ZBH?

Summary

How does Stevanato Group compare to Solventum?

Do analysts rate SOLV or STVN?

Which has more volatility and risk, SOLV or STVN?

Does the media refer more to SOLV or STVN?

Is SOLV or STVN more profitable?

Which has better earnings & valuation, SOLV or STVN?

Summary

How does Stevanato Group compare to Smith & Nephew SNATS?

Which has better earnings and valuation, STVN or SNN?

Which has more risk and volatility, STVN or SNN?

Do insiders and institutionals believe in STVN or SNN?

Does the media prefer STVN or SNN?

Is STVN or SNN more profitable?

Do analysts rate STVN or SNN?

Summary

How does Stevanato Group compare to Penumbra?

Is STVN or PEN more profitable?

Which has more risk & volatility, STVN or PEN?

Do insiders & institutionals believe in STVN or PEN?

Which has higher earnings & valuation, STVN or PEN?

Does the media prefer STVN or PEN?

Do analysts rate STVN or PEN?

Summary

How does Stevanato Group compare to Glaukos?

Is STVN or GKOS more profitable?

Do institutionals and insiders believe in STVN or GKOS?

Do analysts prefer STVN or GKOS?

Does the media refer more to STVN or GKOS?

Which has higher earnings and valuation, STVN or GKOS?

Which has more volatility and risk, STVN or GKOS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STVN vs. The Competition

Stevanato Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools